Journal of Family Planning and Reproductive Health Care 2003: 29(3) What is inflammatory bowel disease (IBD)? Inflammatory bowel disease (IBD) refers to two distinct disorders – Crohn’s disease (CD) and ulcerative colitis (UC).1 These two disorders have distinct clinical and pathological features but their cause is unknown. In patients with large bowel disease only there may be difficulty disti...

Journal of Family Planning and Reproductive Health Care 2003: 29(3) What is inflammatory bowel disease (IBD)? Inflammatory bowel disease (IBD) refers to two distinct disorders – Crohn’s disease (CD) and ulcerative colitis (UC).1 These two disorders have distinct clinical and pathological features but their cause is unknown. In patients with large bowel disease only there may be difficulty disti...

Calprotectin is an abundant neutrophil protein found in both plasma and stool that is markedly elevated in infectious and inflammatory conditions, including inflammatory bowel disease (IBD). We conducted a systematic review of the published literature regarding fecal calprotectin to evaluate its potential as a noninvasive marker of neutrophilic intestinal inflammation. Reference ranges for feca...

Although inflammatory bowel disease (IBD) rarely arises in the setting of solid organ transplantation, IBD has a higher incidence in this setting than in the general population and poses challenging management issues. The most common association is hepatic orthotopic transplant for primary sclerosing cholangitis. This article discusses IBD in the setting of liver transplantation, including both...

introduction due to limitation of colonoscopy in assessing the entire bowel and patients’ intolerance in inflammatory bowel disease (ibd), in the current study, we aimed to prospectively compare the accuracy of 99m tc(v)-dimercaptosuccinic acid (dmsa) and fecal calprotectin with ileocolonoscopy as new methods for localizing inflammations. methods current prospective study conducted between 2012...

A characteristic feature of inflammatory bowel diseases (IBD) is an increased risk neoplasia and colorectal cancer (CRC). The introduction screening programs, as well modern advances in therapy endoscopic technologies, awareness the factors IBD-associated CRC will contribute to reducing frequency this dangerous complication IBD. presented review describes epidemiological data on incidence CRC, ...

Inflammatory bowel disease (IBD), a chronic immunemediated disorder encompassing Crohn’s disease and ulcerative colitis, has the highest prevalence in North America and Europe.[1] The incidence of IBD, however, has been increasing in low prevalence regions such as Asia and the Middle East.[2] The Kingdom of Saudi Arabia (KSA) is one region where this pattern has been noted and described.[3-5] T...

Inflammatory bowel disease mainly consisting of ulcerative colitis and Crohn's disease has been rising gradually during the last two decades in China. In this review article, we provide the latest epidemiological trends in incidence, prevalence, and mortality of IBD patients in China and summarize the risk factors and genetic susceptibility of Chinese IBD patients. We also compare these charact...

UNLABELLED OBJECTIVE; With the increasing use of biologics in patients with inflammatory bowel disease, the Hong Kong IBD Society developed a set of consensus statements intended to serve as local recommendations for clinicians about the appropriate use of biologics for treating inflammatory bowel disease. PARTICIPANTS The consensus meeting was held on 9 July 2011 in Hong Kong. Draft consensu...

Crohn's disease is a chronic relapsing inflammatory bowel disease (IBD). It is characterised by a transmural granulomatous inflammation which can affect any part of the gastrointestinal tract, most commonly the ileum, colon or both. Unlike ulcerative colitis, there may be unaffected bowel between areas of active disease (skip lesions). The clinical course is characterised by exacerbations and r...